Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01-Reference-Cited by-同舟云学术

Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01

Published:2012-05-08 Issue:22 Volume:118 Page:5614-5622
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kidwell Kelley M.,Yothers Greg,Ganz Patricia A.,Land Stephanie R.,Ko Clifford Y.,Cecchini Reena S.,Kopec Jacek A.,Wolmark Norman

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.27593/fullpdf

Reference29 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin.,2010

2. Levamisole and fluorouracil for adjuvant therapy of resented colon carcinoma;Moertel;N Engl J Med.,1990

3. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer;O'Connell;J Clin Oncol.,1997

4. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03;Wolmark;J Clin Oncol.,1993

5. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer;Benson;J Clin Oncol.,2004

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Young-Onset Rectal Cancer;Advances in Surgery;2024-09

2. Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer;JCO Oncology Practice;2024-07-24

3. Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer;Journal of Clinical Oncology;2024-05-01

4. Impact of pain and adverse health outcomes on long-term US testicular cancer survivors;JNCI: Journal of the National Cancer Institute;2023-11-15

5. A randomized controlled trial of hand/foot-cooling by hilotherapy to prevent oxaliplatin-related peripheral neuropathy in patients with malignancies of the digestive system;ESMO Open;2023-04